Keywords: canada, biovail, acquires, enalapril, drugs, merck, co

Canada's Biovail acquires enalapril drugs from Merck & Co for up to $250

Article | 20 May 2002

Print This

Canadian drug developer Biovail has signed an agreement with USpharmaceutical major Merck & Co to acquire US rights to the latter's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in